Cours suspendu

Communiqués Singular Genomics Systems, Inc.

Actions

OMIC

US82933R3084

Equipement et technologie médicale avancés

Marché Fermé - Nasdaq 22:00:00 20/02/2025			Varia. 5j.	Varia. 1 janv.
20,01 ^USD	+0,25%		-.--%	-

28/04	Singular Genomics nomme John Stark au poste de Directeur Général	CI
28/04	Singular Genomics Systems, Inc. annonce la transition de Josh Stahl au poste de membre indépendant du conseil d'administration	CI

Communiqués

24/02/25	Singular Highlights Key G4X™ Launch Milestones and Showcases Groundbreaking 3D Spatial Multiomic Performance at AGBT	AQ
21/02/25	Singular Genomics Announces Closing of Acquisition by Deerfield Management	AQ
21/01/25	SINGULAR GENOMICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Singular Genomics Systems, Inc. - OMIC	BU
07/01/25	SINGULAR GENOMICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Singular Genomics Systems, Inc. - OMIC	BU
23/12/24	Singular Genomics : Enters into Agreement to be Acquired by Deerfield for $20.00 in Cash per Share Form 8 K	PU
23/12/24	Singular Genomics Enters into Agreement to be Acquired by Deerfield for $20.00 in Cash per Share	AQ
12/11/24	Singular Genomics : Reports Recent Updates and Third Quarter 2024 Financial Results Form 8 K	PU
12/11/24	Similar Genomics Systems: Q3 Earnings Snapshot	AQ
12/11/24	Singular Genomics Reports Recent Updates and Third Quarter 2024 Financial Results	AQ
19/09/24	Singular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang Capital	AQ
12/09/24	Singular Genomics Receives Non-Binding Acquisition Proposal from Deerfield	AQ
13/08/24	Similar Genomics Systems: Q2 Earnings Snapshot	AQ
13/08/24	Singular Genomics Reports Recent Highlights and Second Quarter 2024 Financial Results	AQ
30/07/24	Singular Genomics to Report Second Quarter 2024 Financial Results on August 13, 2024	AQ
15/07/24	Singular Genomics Regains Compliance with Nasdaq Minimum Bid Price Requirement	AQ
21/06/24	Singular Genomics Announces 1-for-30 Reverse Stock Split	GL
29/05/24	Singular Genomics to Present at the Goldman Sachs Global Healthcare Conference	AQ
29/05/24	Singular Genomics to Present at the Goldman Sachs Global Healthcare Conference	GL
14/05/24	Similar Genomics Systems: Q1 Earnings Snapshot	AQ
14/05/24	Singular Genomics Reports Recent Highlights and First Quarter 2024 Financial Results	GL
01/05/24	Singular Genomics to Report First Quarter 2024 Financial Results on May 14, 2024	GL
18/03/24	Similar Genomics Systems: Q4 Earnings Snapshot	AQ
18/03/24	Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results	GL
04/03/24	Singular Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024	GL
05/02/24	Singular Genomics Showcases New G4X™ Spatial Sequencer at AGBT and Announces Significant Advances in Throughput, Quality, and Usability for G4® Sequencing Platform	GL